A novel virtual screening procedure identifies Pralatrexate as inhibitor of SARS-CoV-2 RdRp and it reduces viral replication in vitro.
Zhang H, Yang Y, Li J, Wang M, Saravanan KM, Wei J, Tze-Yang Ng J, Tofazzal Hossain M, Liu M, Zhang H, Ren X, Pan Y, Peng Y, Shi Y, Wan X, Liu Y, Wei Y.
Zhang H, et al. Among authors: saravanan km.
PLoS Comput Biol. 2020 Dec 31;16(12):e1008489. doi: 10.1371/journal.pcbi.1008489. eCollection 2020 Dec.
PLoS Comput Biol. 2020.
PMID: 33382685
Free PMC article.